{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/124-US9,335,321(active).pdf"}, "page_content": "10\n\nby microangiography imaging technology in which fluores\n\nThe aim of the third tier is to find out any side effect of the\n\nagent at the concentration level not causing any gross adverse\n\ncent dye, e.g. fluorescent microbead or fluorescent dextrans,\n\nare injected into the blood circulation such that it will be\n\neffects, such as death and malformation in teleost. Therefore,\n\ntests included in the third tier are cellular toxicity test, organ\n\ndiffused to all registered blood vessels by blood circulation.\n\nspecific toxicity test and cardiotoxicity test. In the cytotoxic\n\nAlteration of intersegmental vessels will be an indicator for\n\n15\n\nangiogenic modulating activity. Agent with any positive\n\nity test, number of dead cells (apoptotic cells) is quantified by\n\nflow cytometry. By flow cytometry, one can analyze, in addi\n\nresults in one of the test or negative results in angiogenic\n\nmodulating activity will be discarded. Otherwise, it will be\n\ntion to amount of dead cells, the amount of cells in different\n\nconsidered as safe with angiogenic modulating activity.\n\nstages of cell cycle in a large number of samples, like 300\n\nteleosts in a single experiment. In organ-specific toxicity,\n\nmorphology of an organ is studied by fluorescent in situ\n\nDETAIL DESCRIPTION OF THE INVENTION\n\nhybridization with an organ specific probe. The morphology\n\nThe present invention provides methods for Screening\n\nof the organ is quantified by 3D reconstruction of the optical\n\nagents for angiogenic modulating activity.\n\nsections from confocal images. Any change in the size and\n\nA variety of agents, either synthetic or from natural\n\nshape of the organ may reveal the toxic effects induced by the\n\n25\n\nSources, can be screened using the present invention. Agents\n\nagent tested. Cardiotoxicity tests whether the positive candi\n\ncan be Small molecules in pure form or a crude extract of an\n\ndate is able to affect cardiac functions, such as cardiac output", "type": "Document"}}